Sanfu Paste 2026: China's Dog-Day Herbal Patch for Asthma and Allergic Rhinitis — Final Round Bookings Open

Sanfu Paste 2026: The Final Dog-Day Round Is Bookable Now

Chinese TCM hospitals are taking bookings for the final round of the 2026 sanfu paste season — 末伏 (mo fu, the third dog-day period) begins around August 15, and the therapy's core promise is simple: a few hours of herbal patches on the back in midsummer, aimed at preventing the asthma and allergic-rhinitis flare-ups that arrive with winter.

Sanfu paste (三伏贴) is one of China's most widely used seasonal TCM treatments, applied every year during the three sanfu periods — 初伏 (chu fu, started ~July 16 in 2026), 中伏 (zhong fu, ~July 26), and 末伏 (~August 15). The 2026 season opened on schedule in mid-July, with tertiary TCM hospitals across Beijing, Shanghai, and Chengdu announcing bookings in the same week. For international patients, the practical window that matters is now: the third and final round is the one still open for scheduling, and hospital international departments routinely accommodate foreign visitors.

What the Sanfu Patch Formula Is

The modern formulation is standardized from a classical recipe. The 2024 review in Natural Product Communications ("Composition, Skin Pharmacokinetics, and Pharmacological Effects of the Sanfu Herbal Patch," DOI 10.1177/1934578x241266414) names four core herbs:

The review's pharmacokinetic finding is the part that separates this therapy from folklore: the parent compounds that demonstrably cross the skin barrier — sinapine thiocyanate, asarinin, and tetrahydropalmatine — are the same molecules whose anti-inflammatory, antitussive, and analgesic activities are documented in the pharmacology literature. In other words, the patch is not a placebo delivery system; it is a transdermal formulation whose active constituents are measurable in circulation after application.

The 2024-2025 Evidence Base

The clinical and mechanistic evidence has thickened considerably over the past two years:

• 2024 — Natural Product Communications review (DOI 10.1177/1934578x241266414): documents anti-inflammatory, antitussive, analgesic, and antitumor properties across the formula's bioactive constituents — fatty acids, thioglycosides, essential oils, terpenes, and alkaloids — and maps the skin pharmacokinetics of the three parent compounds.
• 2025 — Journal of Ethnopharmacology mechanism study (DOI 10.1016/j.jep.2025.119867): used TMT quantitative proteomics and molecular docking in an OVA-induced asthma mouse model to trace how dorsal sanfu-patch application exerts its anti-asthma effect at the protein level — the closest the therapy has come to a molecular mechanism-of-action paper.
• 2025 — INPLASY-registered meta-analysis protocol (DOI 10.37766/inplasy2025.9.0042): Shanghai Pudong New Area Pulmonary Hospital registered a systematic review of Chinese herbal medicine (including herbal patches) for allergic rhinitis, covering PubMed, Web of Science, Cochrane, CNKI, and Wanfang through September 2024. The registered subgroup results show significantly lower nasal congestion and itching scores in treated patients (P < 0.0001), with the strongest effects in the 30+ and 40+ age groups.
• Related registered protocols: acupoint herbal patching for functional dyspepsia (INPLASY2025.6.0040), for gastroesophageal reflux disease (INPLASY2025.5.0022), and for peptic ulcer (medRxiv 2024) — evidence that the same patch modality is being studied across chronic indications, not just respiratory disease.

One honest caveat: the INPLASY meta-analysis is registered and protocol-complete but not yet published as a full paper. The headline evidence remains the 2024 review and the 2025 mechanistic study — both peer-reviewed — plus the classical clinical record, which spans centuries of seasonal use and millions of annual applications in China.

Why the Dog Days? The 冬病夏治 Logic

The timing is the therapy. Sanfu paste is built on the classical TCM principle of 冬病夏治 ("winter disease, summer treatment"): chronic cold-type conditions — asthma that worsens in winter, allergic rhinitis that spikes in cold months, cold-aggravated joint pain — are treated during the hottest days of summer, when the body's yang qi is at its annual peak and the lung meridians are most receptive.

In practice, the treatment is a three-visit course timed to the three sanfu periods, each roughly 10 days apart. At each visit the physician places small herbal plasters on classic acupoints — most commonly Feishu (BL-13, lung shu point) on the upper back, Dazhui (DU-14) at the base of the neck, and often bilateral points along the bladder meridian — and the patient wears them for 2-6 hours. A mild local heat and redness reaction is expected and is part of the intended counter-irritant effect; the skin returns to normal within a day or two.

For allergic rhinitis specifically, the treatment logic maps neatly onto the modern allergy calendar: the patch course completes in August, before the autumn pollen and cold-air triggers arrive, and the anti-inflammatory constituents are at steady state by the time the symptom season begins.

Where International Patients Can Get It

Sanfu paste is a standardized seasonal service at essentially every tertiary TCM hospital in China. For international patients, the strongest options combine the therapy itself with established foreign-patient infrastructure:

• Beijing University of Chinese Medicine Dongzhimen Hospital — one of China's flagship TCM teaching hospitals; international department handles bookings, translation, and visa letters.
• Shanghai Yueyang Hospital of Integrated Traditional Chinese and Western Medicine — the leading integrated (中西医结合) hospital in Shanghai, and the natural entry point for patients who want TCM and Western medicine under one roof; see our integrated Chinese-Western medicine guide.
• Chengdu University of TCM Hospital — the center of the Sichuan TCM tradition, with a long history of treating respiratory disease.
• Guangdong Provincial Hospital of TCM (Guangzhou) — among the largest TCM hospitals in southern China, convenient for patients arriving via Hong Kong or the visa-free transit corridors.

All four run international patient desks that can book a sanfu appointment, arrange an English-speaking interpreter, and provide a treatment summary for the patient's home physician. For a broader picture of how TCM access works for foreign visitors, see our TCM in China guide and the Hainan TCM wellness tourism overview.

Hainan Boao Lecheng and the Visa-Free Angle

For patients traveling from Southeast Asia and the Middle East — the largest inbound groups for Chinese medical services — the Hainan route deserves specific mention. Hainan's visa-free entry policy covers citizens of most Asian and Middle Eastern countries for stays up to 30 days, and the island's Boao Lecheng pilot zone has built out TCM-adjacent wellness services alongside its famous imported-drug and cell-therapy programs. A sanfu course is short enough (one visit, or three visits spread across two weeks) to fit comfortably inside a Hainan visa-free stay, and the island's Sanya Hospital of Traditional Chinese Medicine runs seasonal sanfu services each summer.

For patients needing a longer or multi-city itinerary, the standard China medical visa guide covers the M-visa invitation-letter process, which major hospitals issue within 1-3 working days.

Cost and Access Logistics

The cost structure is one of the therapy's quiet advantages:

• Patch cost: ¥80-200 RMB (about $11-$28 USD) per patch at tertiary public hospitals — three patches per visit, three visits per full course.
• Full course: roughly ¥720-1,800 RMB ($100-$250 USD), typically including the consultation.
• Comparison: a year of Western seasonal allergy management — antihistamines, intranasal corticosteroids, and two specialist visits — runs $300-$1,200 USD in most countries. Sanfu paste is a seasonal, non-daily intervention at 60-75% less than the equivalent care in Singapore, Korea, or the United States.
• No insurance needed: the treatment is inexpensive enough to self-pay without involving travel insurance or hospital deposit structures; most international departments take card payment on the day.

What to Watch Over the Next 12-18 Months

Three developments are worth tracking:

1. Publication of the Shanghai Pudong meta-analysis — the INPLASY-registered allergic-rhinitis review (protocol-complete as of September 2025) is expected to publish in late 2026 or early 2027. A peer-reviewed meta-analysis would materially strengthen the evidence grade for the patch modality.
2. More registered protocols reaching completion — the functional dyspepsia, GERD, and peptic ulcer protocols registered through 2024-2025 will report in sequence, broadening sanfu-style patching beyond respiratory disease.
3. WHO traditional medicine strategy milestones — the WHO's 2025-2034 traditional medicine strategy continues to normalize TCM modalities in international clinical guidelines, which feeds directly into how confidently Western-trained physicians view a therapy like sanfu paste when a patient brings it up.

For patients, none of this changes the immediate decision: the therapy is low-cost, low-risk when applied by a qualified TCM physician, and the 2026 access window is open now.

What to Ask Before Booking

A short checklist for the consultation:

• Does my condition qualify? Asthma, allergic rhinitis, chronic bronchitis, stable COPD, chronic degenerative joint disease, and chronic gastritis are the six listed indications. Acute infection, fever, broken skin at the application site, and pregnancy are standard exclusions.
• What should I bring? A medication list, allergy history, and any prior pulmonary function tests or allergy panel results — the physician will use them to confirm the indication and rule out contraindications.
• What happens at the visit? A 15-30 minute consultation, patch placement, and 2-6 hours of wear time. Mild local redness and warmth are expected; severe blistering is not, and should be reported immediately.
• Can I combine it with Western treatment? Yes — and this is where China differs from most Western clinics: the same hospital (or the same campus, at integrated hospitals like Yueyang Shanghai) can coordinate the sanfu course with ongoing Western asthma or allergy medication. See how integrated Chinese-Western medicine works in practice.
• What if I only have time for one round? A single 末伏 application is a legitimate course for first-time patients; many hospitals offer it standalone, and it is the standard entry point for short-stay medical visitors.

How China Hospitals Guide Helps

China Hospitals Guide provides independent coordination for international patients seeking care at Chinese hospitals — including seasonal TCM services like sanfu paste, integrative respiratory programs, and full coordination for commercially approved therapies.

What we do:

• Match you to the right TCM or integrated hospital for your condition (asthma, allergic rhinitis, COPD, chronic pain)
• Pre-arrange English, Bahasa Indonesia, Vietnamese, Russian, or Arabic interpretation
• Coordinate M-visa invitation letters and arrival logistics
• Book the sanfu appointment slot directly with the hospital's international department
• Provide a treatment summary in English for your home physician to follow

Start a free case review — no commitment, no fee.

Related Reading

• TCM in China: A Complete Guide to Traditional Chinese Medicine for International Patients
• Integrated Chinese-Western Medicine in China: How It Works in Practice
• China's 2026-30 TCM Five-Year Plan: What 1.82B Annual Visits Mean for International Patients
• Hainan TCM Wellness Tourism 2026: What International Patients Can Access
• Acupuncture Treatment in China: A Guide for International Patients
• China Medical Visa Guide 2026: Entry Options for Treatment Stays